CHRISTOPHER MARSH: Open Payments
NPI 1033428362 · CAPE MAY COURT HOUSE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,070 in 217 payments from 20 companies in 2025. Trend: 2023 $1,476 · 2024 $2,582 · 2025 $3,070
Food & beverage: $2,930Education: $140
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 32 | $472 |
| Almirall LLC | 32 | $370 |
| ABBVIE INC. | 29 | $279 |
| UCB, Inc. | 18 | $240 |
| Galderma Laboratories, L.P. | 16 | $217 |
| PFIZER INC. | 14 | $200 |
| Novartis Pharmaceuticals Corporation | 7 | $187 |
| Regeneron Healthcare Solutions, Inc. | 4 | $166 |
| Lilly USA, LLC | 13 | $166 |
| E.R. Squibb & Sons, L.L.C. | 17 | $159 |
Products named: TREMFYA, Seysara, Bimzelx, NEMLUVIO, SKYRIZI, CIBINQO, DUPIXENT, TALTZ.
Industry payments across NJ — which companies pay providers there.
